Advisory board
Dr. Clifford Siporin
Dr. Siporin has over 30 years of experience in the Pharmaceutical industry and has accomplishments in all areas of drug development. Designed, established and implemented a unique and highly successful program to develop, register and market pharmaceutical products worldwide including extending brand penetration and market share of in a wide range of therapeutic areas. Direct, relevant experience in drug substance and drug product issues as they relate to manufacturing and control, pre-clinical and clinical studies and regulatory parameters related to drug approval, manufacturing, labeling, marketing and distribution.
Dr. Siporin is the founder of Florida based GREYSTONE PHARMACEUTICAL CONSULTING, INC. It is a full service CRO with expertise including contract project management and site monitoring, statistics, manufacturing, IRB, Sponsor, IRB and site auditing, medical and scientific writing and regulatory affairs (FDA) and product safety issues. Recent assignments include providing expert testimony in multiple high profile legal cases dealing with patent infringement, drug labeling, pharmacovigilance and other general pharmaceutical and device issues, FDA regulations and product safety and efficacy issues including appearance in State and Federal Court. NIH-NIAID-DMID national grant reviewer for regulatory affairs proposals.
Dr. Siporin has done is doctorate in Microbiology from the University of Dayton, Dayton, Ohio in 1976. His professional affiliations and activities are as given below:
- Member, American Society for Microbiology (A.S.M.)
- Member, Continuing Education Committee of A.S.M.
- Fellow, American Academy of Microbiology
- Lecturer, A.S.M. National Foundation
- Member, Drug Information Association
- M.I.T. Forum, Chicago Branch
- Licensing Executives Society